Novel Approaches for Metabolomics in Drugs and Biomarkers Discovery: 2nd Edition
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Advances in Metabolomics".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 125
Special Issue Editor
Interests: biomarkers discovery; drugs discovery; metabolomics; FTIR spectroscopy; diagnostic; prognosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metabolomics, by providing a direct vision of the functional metabolic outcome of a given biological system, can enable the discovery of diverse sub-classes of pathophysiological states. This potentiates the discovery of new drug targets and biomarkers, enabling a more precise disease diagnosis and prognosis. The holistic molecular signature captured by metabolomics can also be used to evaluate the effect of drugs and, consequently, to monitor and optimize drug therapies. All of this will contribute towards a more precise and efficient use of medicine.
To further potentiate these discoveries, this Special Issue focuses on new approaches in metabolomics enabling the classification of the biological system towards the discovery of drug and disease biomarkers. The topics covered by this Special Issue will include (not exclusively) advances on:
- New methodologies to capture the physiological state of the system.
- Metabolome perturbation according to pathophysiological states.
- Metabolome perturbation due to drugs, and other environmental variables.
Dr. Cecília R.C. Calado
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolomics
- drugs discovery
- biomarkers discovery
- diagnostic
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
